SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $64,000 | +1.6% | 116,500 | 0.0% | 0.00% | – |
| Q1 2016 | $63,000 | -40.0% | 116,500 | 0.0% | 0.00% | – |
| Q4 2015 | $105,000 | +11.7% | 116,500 | 0.0% | 0.00% | – |
| Q3 2015 | $94,000 | -73.2% | 116,500 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $351,000 | +27.2% | 116,500 | 0.0% | 0.00% | – |
| Q1 2015 | $276,000 | 0.0% | 116,500 | 0.0% | 0.00% | – |
| Q4 2014 | $276,000 | -70.4% | 116,500 | -10.9% | 0.00% | -100.0% |
| Q3 2014 | $933,000 | -14.8% | 130,719 | -22.2% | 0.00% | 0.0% |
| Q2 2014 | $1,095,000 | +7.8% | 167,962 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,016,000 | +88.8% | 167,962 | +44.2% | 0.00% | 0.0% |
| Q4 2013 | $538,000 | -7.9% | 116,500 | -1.1% | 0.00% | 0.0% |
| Q3 2013 | $584,000 | +9.8% | 117,800 | +15.3% | 0.00% | 0.0% |
| Q2 2013 | $532,000 | – | 102,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |